Alendronate News
Amgen says denosumab improves bone vs Fosamax
Amgen Inc said on Monday a trial of its experimental osteoporosis drug, denosumab, showed it increased bone density at the hip in post- menopausal women who switched from Merck & Co Inc's Fosamax.
Wal-Mart Expands Prescription Program for Generics
Wal-Mart says it will sell discounted 90-day supplies of up to 350 generic products as the third phase of its $4 prescription program. The discounted drugs will be available at Wal-Mart, Neighborhood Market and Sam’s Club...
Alendronate warning on atrial fibrillation
A drug commonly used to treat osteoporosis in women could increase atrial fibrillation (AF) risk and may account for 3 per cent of all cases of the condition, US research suggests.
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax®
Teva Pharmaceutical Industries Ltd. (Ticker: TEVA) announced the following decisions by two European courts:
Generic Fosamax Approved
The U.S. Food and Drug Administration approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.